The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics

Author： The BENEDICT Group  

Publisher： Elsevier

ISSN： 0197-2456

Source： Controlled Clinical Trials, Vol.24, Iss.4, 2003-08, pp. : 442-461

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Arthritis, Diet and Activity Promotion Trial (ADAPT): design, rationale, and baseline results

By Miller G.D.   Rejeski W.J.   Williamson J.D.   Morgan T.   Sevick M.A.   Loeser R.F.   Ettinger W.H.   Messier S.P.   for the ADAPT investigators  

Controlled Clinical Trials, Vol. 24, Iss. 4, 2003-08 ,pp. : 462-480

Elsevier

Access to resources Recommend Favorite

The Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study: design and baseline characteristics

By Bots M.L.   Evans G.W.   Riley W.   Meijer R.   McBride K.H.   Paskett E.D.   Helmond F.A.   Grobbee D.E.   for the OPAL Investigators  

Controlled Clinical Trials, Vol. 24, Iss. 6, 2003-12 ,pp. : 752-775

Elsevier

Access to resources Recommend Favorite

Baseline

By  

Journal of Pain Management, Vol. , Iss. , 2017-01 ,pp. : 42-42

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Baseline

By  

Journal of Pain Management, Vol. , Iss. , 2017-01 ,pp. : 32-32

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Baseline

By  

Journal of Pain Management, Vol. , Iss. , 2017-01 ,pp. : 95-94

Nova Science Publishers, Inc.

Access to resources Recommend Favorite